Health News (Reuters)
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
Updated: 3 years 45 weeks ago
France to lift the 100 km travel restriction on June 2: PM
France on June 2 will lift an 100 km (62 mile) travel restriction imposed to contain the new coronavirus outbreak, Prime Minister Edouard Philippe said on Thursday.
Categories: Health
EU launches new COVID-19 fundraising to address concerns over equal access
The European Commission launched a new global fundraising campaign on Thursday to finance the development and worldwide distribution of testing, vaccines and treatments against COVID-19, seeking to address concerns they may not be equally shared.
Categories: Health
Main sports events in France to remain suspended until June 21: PM
Major sporting events in France will remain suspended for now until at least June 21, Prime Minister Edouard Philippe said on Thursday.
Categories: Health
Italy records 70 new coronavirus deaths, 593 new cases
Deaths from the COVID-19 epidemic in Italy climbed by 70 on Thursday, against 117 the day before, the Civil Protection Agency said, while the daily tally of new cases edged up to 593 from 584 on Wednesday.
Categories: Health
France to speed up re-opening of schools: PM
France will accelerate a plan a plan to re-open high schools and junior high schools across the country, Prime Minister Edouard Philippe said on Thursday.
Categories: Health
AstraZeneca says it may consider exposing vaccine trial participants to virus
The chief executive of AstraZeneca , which is developing a leading coronavirus vaccine with Oxford University, said it is too early to deliberately expose trial participants to the pathogen, but it may become an option if ongoing tests hit a snag.
Categories: Health
Coronavirus reproduction rate below one in most of France: minister
The reproduction rate of the coronavirus infection is below 1 in most of France's national territory, Health Minister Olivier Veran said on Thursday.
Categories: Health
Exclusive: GSK says science does not link pandemic H1N1 flu vaccine to sleep disorder
British drugmaker GSK said on Thursday that its previous flu pandemic vaccine, which used some of the same ingredients as COVID-19 vaccines currently under development, was not linked to a rise in cases of the sleep disorder narcolepsy.
Categories: Health
Health results are good in France regarding coronavirus: PM
Health results have been good so far in France, Prime Minister Edouard Philippe said on Thursday, as the country prepares to enter a second phase in its relaxation of lockdown rules on June 2.
Categories: Health
Mumbai DJ swaps deck for doctor's scrubs to fight coronavirus
As India's financial capital Mumbai battled a growing number of coronavirus cases, local DJ Sanjay Meriya set aside his turntable and dusted off a long-unused medical degree in order to help out.
Categories: Health
AstraZeneca partners with Oxford Biomedica to expand COVID-19 vaccine manufacturing capacity
AstraZeneca has partnered with British cell therapy company Oxford Biomedica to make its experimental COVID-19 vaccine, as the drugmaker looks to bolster its manufacturing capacity to produce one billion doses.
Categories: Health
EU plans permanent stockpile of essential drugs, medical gear
The European Commission said on Thursday it wanted to set up a permanent reserve of essential drugs and medical equipment to address shortages that have dogged the EU for years and worsened throughout the COVID-19 pandemic.
Categories: Health
LabCorp ties up with software provider to expand virtual clinical trials
Laboratory Corporation of America Holdings (LabCorp) said on Thursday it was partnering with software provider Medable to speed up the adoption of virtual clinical trials, as many participants are dropping out of ongoing studies due to the COVID-19 pandemic.
Categories: Health
Indonesia to keep prescribing two malaria drugs for COVID-19 despite bans in Europe
Indonesia will continue to prescribe two anti-malaria drugs for coronavirus patients but monitor their use closely, a spokesman for Indonesia COVID-19 taskforce said on Thursday, after some European nations banned the drug over safety concerns.
Categories: Health
CVS Health to open last of 1,000 drive-thru COVID-19 testing sites
CVS Health Corp said on Thursday it would open more COVID-19 testing sites at some of its pharmacy drive-thru locations, completing the last leg of the drugstore chain's planned 1,000 sites across more than 30 U.S. states.
Categories: Health
GSK aims for one billion doses of booster as COVID-19 vaccine race heats up
GSK , the world's largest vaccine maker, laid out plans on Thursday to produce 1 billion doses of vaccine efficacy boosters for COVID-19 shots next year, as the race to develop a successful solution to the coronavirus crisis heats up.
Categories: Health
Coronavirus patients flood hospitals in Indonesia's second-largest city
Hospitals in Indonesia's second largest city of Surabaya have been overwhelmed by a surge of new coronavirus cases, forcing them to turn patients away, the Indonesian Medical Association said on Thursday.
Categories: Health
WHO official: European deaths spike since March linked to COVID-19
About 159,000 more people in 24 European countries have died since early March than would have ordinarily been expected, a World Health Organization (WHO) official said on Thursday, with a "significant proportion" of the spike linked to COVID-19.
Categories: Health
Africa hit by sustained community spread of coronavirus: disease centre
Cases of community transmission of the new coronavirus are growing in Africa, particularly in Ethiopia, and a new strategy for testing is needed to prevent this, the head of the Africa Centres for Disease Control and Prevention said on Thursday.
Categories: Health
No preferential access to Themis' potential COVID-19 vaccine: CEO
Nobody will get preferential access to a potential COVID-19 drug developed by vaccine maker Themis Bioscience, which is being bought by U.S. pharmaceuticals firm Merck & Co Inc, the Austrian firm's chief executive said on Thursday.
Categories: Health
